Who really needs a heart calcium scan?

A recent ten‑year study involving more than 6,000 adults examined the added value of coronary calcium scoring—an imaging test that quantifies calcified plaque in the coronary arteries—when used alongside conventional heart‑disease risk calculators. The researchers found that, for the majority of participants, the calcium scan did not significantly alter the risk assessment derived from standard tools such as the Framingham or ACC/AHA ASCVD risk equations.

However, the study highlighted a distinct benefit for individuals who fall into borderline or intermediate risk categories according to these traditional models. In that subgroup, the presence or absence of coronary calcium helped clinicians better stratify patients, identifying those who were actually more likely to develop cardiovascular events. The findings suggest that while routine calcium scoring may not be necessary for low‑ or high‑risk patients, it can provide meaningful prognostic information for those whose risk estimates are less clear.

The authors conclude that coronary calcium scanning should be considered selectively, particularly for patients whose standard risk calculations do not provide a definitive treatment direction. This targeted approach could improve decision‑making regarding preventive therapies such as statins or lifestyle interventions, potentially reducing unnecessary medication use and focusing resources on those most likely to benefit.